INFORMATION FOR OPTIMAL USE OF APPENDIX B:

These tables are designed to provide a snapshot of the pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP) and treatment MCMs available for select biothreats.  This appendix will be updated as rapidly as possible as new threats emerge, or as new information on MCMs are developed. For additional information on vaccines, DHA maintains a website that displays vaccination recommendations by CCMD (https://www.health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Recommendations/Vaccine-Recommendations-by-AOR). There are nuances to utilization of many of these MCMs, so utilize the hyperlinks for references given by agent for dosing and duration. Given that FDA labels are periodically updated or generic manufacturers change, so hyperlinks to labels are not included by MCM. Either DAILYMED (https://dailymed.nlm.nih.gov/dailymed/index.cfm) or Drugs@FDA  (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm ) can be utilized to find the most up-to-date product labels. DAILYMED has more user-friendly search features but note that the "in use" labeling on DailyMed may not be identical to the most recent FDA-approved labeling available at Drugs@FDA, or the labeling distributed with products. This appendix also links to additional information on potential uses of repurposed MCMs within the practitioner-patient relationship (CAC enabled website: https://pki.jacks.jpeocbrnd.army.mil/JPMCBRNMedical/Dashboard/RaidrSummaries).  Finally, the U.S. Army Medical Materiel Development Activity (USAMMDA) provides a number of Force Health Protection (FHP) protocols and are noted in the tables below if available.

For more information, contact: USAMMDA FHP protocol portfolio: 301-401-2768 (24/7), Email: usarmy.detrick.medcom-usammda.mbx.force-health-protection@health.mil